Beyond Air has filed a notice of an exempt offering of securities to raise $20,600,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Beyond Air is raising up to $20,600,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Douglas Larson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Beyond Air
AIT Therapeutics, commencing June 26, 2019 is named Beyond Air. The Beyond Air team is setting new standards for the industry, leveraging their depth of clinical wisdom, innovation, and passion. Steadfast in their commitment to harness the power of nitric oxide, theyre revolutionizing care to transform more lives. The LungFit family of products are designed by the same inventors who developed the first nitric oxide delivery system and other systems in use worldwide.
To learn more about Beyond Air, visit http://www.beyondair.net/
Beyond Air Linkedin Page: https://www.linkedin.com/company/beyondair/
Contact:
Douglas Larson, Chief Financial Officer
516-665-8200
https://www.linkedin.com/in/larsondouglas/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.